AbbVie to acquire UK-based antibody medicines company DJS Antibodies

By NS Healthcare Staff Writer21 Oct 2022

DJS Antibodies is engaged in the development and commercialisation of antibody medicines that target difficult-to-drug disease-causing proteins, and its lead programme, DJS-002 is currently being studied in Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases

HOOKIPA, Roche sign licensing deal for KRAS-mutated cancer....

Roche will pay an upfront amount of $25m to HOOKIPA Pharma and

Jazz Pharmaceuticals, Zymeworks sign licence deal for zanidatamab

Under the terms of the deal, Jazz will obtain exclusive rights to

Novavax gets FDA EUA for COVID-19 Vaccine, Adjuvanted....

The FDA Emergency Use Authorisation decision was based on the findings of

Deck the Halls this Winter with New Limited-Edition....

Introducing Voortman® holiday wafers and cookies, now on shelves across the U.S.

Pharmaceuticals

Lilly to acquire genetic medicine company Akouos for $487m
19 Oct 22

LG Chem to buy oncology-focussed biopharma firm AVEO for $566m
19 Oct 22

Gilead, MacroGenics collaborate on bispecific antibodies
18 Oct 22

Patient Care

Medlab Middle East generated business worth AED469 million during the 2022 exhibition in Dubai
28 Sep 22

GSK, Microsoft partner with CHDS Nepal on disease surveillance project
22 Sep 22

bluebird bio gets FDA approval for Skysona to treat cerebral adrenoleukodystrophy
19 Sep 22

Nutraceuticals

Multicultural Foodservice & Hospitality Alliance and Unilever Food Solutions’ #FairKitchens Helps “ELEVATE” Diversity, Equity and Inclusion in the Restaurant, Foodservice and Hospitality Industry
19 Oct 22

The Vitamin Shoppe’s BodyTech® Sports Nutrition Brand and Warner Bros. Consumer Products Launch Exclusive Flavor Collaborations Inspired by Characters from the DC Universe including Superman, Batman, Wonder Woman, Black Adam and More
19 Oct 22

Global Cannabidiol Legalization Trend to Shape the CBD Market’s Future Growth
19 Oct 22

OUR TITLES

MOST READ

Milestone Pharmaceuticals’ etripamil nasal spray meets primary endpoint of phase 3 trial in PSVT

EMA’s CHMP recommends approval for Boehringer Ingelheim’s spesolimab

UK announces over £800m funding to improve innovation, growth and patient safety

Odyssey Therapeutics secures $168m in Series B financing round

AdAlta partners with GPCR Therapeutics for new cancer treatment

Recommended Companies

Arjo
20 Sep 22

Randox Biosciences
06 Feb 18

Thermo Scientific
30 Sep 14

Kerry Bio-Science
18 Jul 13

Facilities

Global survey reveals food prices vastly....
14 Oct 22

BioNTech enters mRNA research partnership with....
07 Oct 22

Novo Nordisk teams up with Microsoft....
13 Sep 22

WuXi STA opens new oligonucleotide and....
07 Jul 22

DEALS

AstraZeneca’s Alexion to buy LogicBio to....
04 Oct 22

Myovant rejects Sumitovant Biopharma’s $2.5bn takeover....
03 Oct 22

GENFIT to acquire Swiss biotech company....
20 Sep 22

EC blocks Illumina’s $7.1bn acquisition of....
07 Sep 22

CONTRACTS

AstraZeneca, Gatehouse Bio extend partnership to....
09 Sep 22

Moderna to supply additional doses of....
01 Aug 22

Bavarian Nordic to supply additional monkeypox....
18 Jul 22

GenScript, ACT Therapeutics partner to develop....
13 Jul 22

Company Insight